Interestingly, neither Squamous Cell Carcinoma in situ (SCCIS) nor cSCC showed a significant upregulation of ALDH3A1 and IGFBP2, and ALDH3A1 was even found to be downregulated in cSCC. The gene discussed is ALDH3A1; the disease is squamous carcinoma in situ.